http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112807288-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_246146645c44b223b6a2e9a82d4287a9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y30-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y30-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y40-00
filingDate 2021-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_050471c7aef086ff5801b11218670fa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b23bf743992c2a265179f811364a36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_146440b22c29c76a82db605915f66393
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcdedb1d2fb313a317c6d186463125ec
publicationDate 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112807288-A
titleOfInvention A kind of preparation method of neutrophil membrane biomimetic nanomaterial specifically targeting infection site
abstract The invention discloses a preparation method of a neutrophil membrane biomimetic nanomaterial specifically targeting an infection site, comprising the following steps: mixing the neutrophil membrane and drug-loading nanoparticles, performing ultrasonic mixing on the obtained mixture, and then passing through the volume of The free cell membrane microspheres and drug-loaded nanoparticles were separated by size exclusion chromatography to obtain purified neutrophil membrane biomimetic nanomaterials. The preparation method has the advantages of simple operation, low cost and short preparation period. The prepared neutrophil membrane biomimetic nanomaterial uses PLGA as the shell of the nanoparticle, which encapsulates the therapeutic drug, and the surface of the shell wraps the neutrophil membrane, so that the nanoparticle has the in vivo targeting ability of actively targeting the infection site, so as to improve the The purpose of the drug concentration in the infected tissue around the joint prosthesis is to improve the targeted therapeutic effect of the drug on the infection site.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115245500-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114469889-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112941025-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112941025-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113952461-A
priorityDate 2021-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2707
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23692753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452041512
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID510082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491273

Total number of triples: 56.